BUNKER KEVIN D. (Chief Operating Officer) received a stock award from ZENTALIS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/1/2023ACC: 0001725160-23-000020
Officer· Chief Operating Officer
Since Apr 2020
+194K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
224K acquired · 30K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−30K
Price / share
—
Trade value
—
% of position
3.7%
11/9/2022
814.11K→784.11K
Common Stock
Direct
Shares
+91.35K
Price / share
—
Trade value
—
% of position
11.7%
2/1/2023
784.11K→875.46K
Total
Net shares
+61.35K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/9/2022 | G · Gift | −30K | — | — | 3.7% | 814.11K | 784.11K |
| Common Stock Direct | 2/1/2023 | A · Award | +91.35K | — | — | 11.7% | 784.11K | 875.46K |
| Total | +61.35K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
132.65K shares
Shares
+132.65K
Strike price
23.65
Held after
132.65K
Exercisable
—
2/1/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock132.65K shares | 2/1/2023 | A · Award | +132.65K | 23.65 | — | 132.65K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned95K
Common Stock
IndirectShares owned350.00
Total
95.35K indirect95.35K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 95K | Indirect |
| Common Stock | 350.00 | Indirect |
| Total | 95.35K | 95.35K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported